(Q34539360)

English

Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF) (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

United States of America

0 references

hospitalization

1 reference

based on heuristic

inferred from title

author name string

Arash Naeim

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Henry J Henk

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Laura Becker

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Victoria Chia

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sejal Badre

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Xiaoyan Li

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Robert Deeter

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

8 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: A retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Trends in neutropenia-related inpatient events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practices.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Risks and consequences of chemotherapy-induced neutropenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Risk models for predicting chemotherapy-induced neutropenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Filgrastim in patients with neutropenia: potential effects on quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

7 July 2018

Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-11

21 January 2018

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-11

21 January 2018

Open-label, Randomized Study of Pegfilgrastim vs. Daily Filgrastim as an Adjunct to Chemotherapy in Elderly Patients with Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-11

21 January 2018

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-11

21 January 2018

Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-11

21 January 2018

Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-11

21 January 2018

Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-11

21 January 2018

Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-11

21 January 2018

Health Insurance Portability and Accountability Act of 1996. Public Law 104-191.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

27 October 2018

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3559272

9 December 2018

Protection of human subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/23298389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The economics of febrile neutropenia: implications for the use of colony-stimulating factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23298389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost of neutropenic complications of chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23298389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-13-11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34539360&oldid=2196754686"